Xiaoqin Liu

Xiaoqin Liu

Auto-generated profile, based on publicly available information

Xiaoqin Liu

NCRR‐The National Centre for Register‐Based Research, Department of Public Health Aarhus University Aarhus Denmark

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
XLXiaoqin Liu
Xiaoqin Liu
EAEsben Agerbo
Esben Agerbo
Vivi SchlünssenVivi Schlünssen
Vivi Schlünssen
RWRosalind J. Wright
Rosalind J. Wright
JLJiong Li
Jiong Li
TMTrine Munk-Olsen
Trine Munk-Olsen

6 September 2017 in BMJ
Verified
Journal Article
Open access
PDF file
XLXiaoqin Liu
Xiaoqin Liu
EAEsben Agerbo
Esben Agerbo
KIKatja G Ingstrup
Katja G Ingstrup
KMKatherine Musliner
Katherine Musliner
SMSamantha Meltzer-Brody
Samantha Meltzer-Brody
TMTrine Munk-Olsen
Trine Munk-Olsen
Objective To investigate the association between in utero exposure to antidepressants and risk of psychiatric disorders. Design Population based cohort study. Setting Danish national registers. Participants 905 383 liveborn singletons born during 1998-2012 in Denmark and followed from birth until July 2014, death, emigration, or date of first psychiatric diagnosis, whichever came first. The children were followed for a maximum of 16.5 years and contributed 8.1×106 person years at risk. Exposures for observational studies Children were categorised into four groups according to maternal antidepressant use within two years before and during pregnancy: unexposed, antidepressant discontinuation (use before but not during pregnancy), antidepressant continuation (use both before and during pregnancy), and new user (use only during pregnancy). Main outcome measure First psychiatric diagnosis in children, defined as first day of inpatient or outpatient treatment for psychiatric disorders. Hazard ratios of psychiatric disorders were estimated using Cox regression models. Results Overall, psychiatric disorders were diagnosed in 32 400 children. The adjusted 15 year cumulative incidence of psychiatric disorders was 8.0% (95% confidence interval 7.9% to 8.2%) in the unexposed group, 11.5% (10.3% to 12.9%) in the antidepressant discontinuation group, 13.6% (11.3% to 16.3%) in the continuation group, and 14.5% (10.5% to 19.8%) in the new user group. The antidepressant continuation group had an increased risk of psychiatric disorders (hazard ratio 1.27, 1.17 to 1.38), compared with the discontinuation group. Conclusions In utero exposure to antidepressants was associated with increased risk of psychiatric disorders. The association may be attributable to the severity of underlying maternal disorders in combination with antidepressant exposure in utero. The findings suggest that focusing solely on a single psychiatric disorder among offspring in studies of in utero antidepressant exposure may be too restrictive.

1 October 2022 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
MKMette-Marie Zacher Kjeldsen
Mette-Marie Zacher Kjeldsen
ABAlessio Bricca
Alessio Bricca
XLXiaoqin Liu
Xiaoqin Liu
VFVibe G. Frokjaer
Vibe G. Frokjaer
KMKathrine Bang Madsen
Kathrine Bang Madsen
TMTrine Munk-Olsen
Trine Munk-Olsen
Importance: Current evidence on the association between family history of psychiatric disorders and postpartum depression is inconsistent; family studies have identified familial risk of postpartum depression, whereas systematic reviews and umbrella reviews, compiling all risk factors for postpartum depression, often have not.Objective: To investigate the association between family history of psychiatric disorders and risk of developing postpartum depression within 12 months post partum.Data Sources: Literature searches were conducted in PubMed, Embase, and PsycINFO in September 2021 and updated in March 2022, accompanied by citation and reference search.Study Selection: Studies eligible for inclusion comprised peer-reviewed cohort and case-control studies reporting an odds ratio (OR) or sufficient data to calculate one for the association between family history of any psychiatric disorder and postpartum depression. Study selection was made by 2 independent reviewers: title and abstract screening followed by full-text screening.Data Extraction and Synthesis: Reporting was performed using the MOOSE checklist. Two reviewers independently extracted predefined information and assessed included studies for risk of bias using the Newcastle-Ottawa Scale. Data were pooled in a meta-analysis using a random-effects model. Heterogeneity was investigated with meta-regression, subgroup, and sensitivity analyses. Publication bias was investigated using a funnel plot, and GRADE (Grading of Recommendations Assessment, Development, and Evaluation) was used to evaluate the overall certainty of the findings.Main Outcomes and Measures: The primary outcome was the pooled association between family history of psychiatric disorders and postpartum depression.Results: A total of 26 studies were included, containing information on 100 877 women. Meta-analysis showed an increased OR of developing postpartum depression when mothers had a family history of psychiatric disorders (OR, 2.08; 95% CI, 1.67-2.59; I2 = 57.14%) corresponding to a risk ratio of 1.79 (95% CI, 1.52-2.09), assuming a 15% postpartum depression prevalence in the general population. Subgroup, sensitivity, and meta-regression analyses were in line with the primary analysis. The overall certainty of evidence was deemed as moderate according to GRADE.Conclusions and Relevance: In this study, there was moderate certainty of evidence for an almost 2-fold higher risk of developing postpartum depression among mothers who have a family history of any psychiatric disorder compared with mothers without.

30 August 2019 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
XLXiaoqin Liu
Xiaoqin Liu
SDSøren Dalsgaard
Søren Dalsgaard
TMTrine Munk-Olsen
Trine Munk-Olsen
JLJiong Li
Jiong Li
RWRosalind J. Wright
Rosalind J. Wright
NMNatalie C. Momen
Natalie C. Momen

21 March 2015 in Pediatric Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
XLXiaoqin Liu
Xiaoqin Liu
JOJørn Olsen
Jørn Olsen
EAEsben Agerbo
Esben Agerbo
WYWei Yuan
Wei Yuan
CWChun Sen Wu
Chun Sen Wu
JLJiong Li
Jiong Li

30 September 2022 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
TMTrine Munk-Olsen
Trine Munk-Olsen
XLXiaoqin Liu
Xiaoqin Liu
KMKathrine Bang Madsen
Kathrine Bang Madsen
MKMette-Marie Zacher Kjeldsen
Mette-Marie Zacher Kjeldsen
LPLiselotte Vogdrup Petersen
Liselotte Vogdrup Petersen
MMMerete L. Maegbaek
Merete L. Maegbaek
Postpartum depression (PPD) is a serious condition associated with potentially tragic outcomes, and in an ideal world PPDs should be prevented. Risk prediction models have been developed in psychiatry estimating an individual’s probability of developing a specific condition, and recently a few models have also emerged within the field of PPD research, although none are implemented in clinical care. For the present study we aimed to develop and validate a prediction model to assess individualized risk of PPD and provide a tentative template for individualized risk calculation offering opportunities for additional external validation of this tool. Danish population registers served as our data sources and PPD was defined as recorded contact to a psychiatric treatment facility (ICD-10 code DF32-33) or redeemed antidepressant prescriptions (ATC code N06A), resulting in a sample of 6,402 PPD cases (development sample) and 2,379 (validation sample). Candidate predictors covered background information including cohabitating status, age, education, and previous psychiatric episodes in index mother (Core model), additional variables related to pregnancy and childbirth (Extended model), and further health information about the mother and her family (Extended+ model). Results indicated our recalibrated Extended model with 14 variables achieved highest performance with satisfying calibration and discrimination. Previous psychiatric history, maternal age, low education, and hyperemesis gravidarum were the most important predictors. Moving forward, external validation of the model represents the next step, while considering who will benefit from preventive PPD interventions, as well as considering potential consequences from false positive and negative test results, defined through different threshold values.